<--- Back to Details
First PageDocument Content
Yeasts / Fungal diseases / Antifungals / Tremellomycetes / Amphotericin B / Cryptococcus neoformans / Visceral leishmaniasis / Candida lusitaniae / Liposome / Biology / Microbiology / Mycology
Date: 2013-08-21 15:23:34
Yeasts
Fungal diseases
Antifungals
Tremellomycetes
Amphotericin B
Cryptococcus neoformans
Visceral leishmaniasis
Candida lusitaniae
Liposome
Biology
Microbiology
Mycology

Microsoft Word - 12C019-AMB-WPI.doc

Add to Reading List

Source URL: www.astellas.us

Download Document from Source Website

File Size: 536,78 KB

Share Document on Facebook

Similar Documents

Clinical medicine / Medicine / RTT / Chemistry / Insulin / Epinephrine / Amphotericin B / Medical error / Promethazine / Midazolam / Furosemide / Lidocaine

ismp-hosp-temp-MASTER.qxd

DocID: 1qIK8 - View Document

Antifungals / Ergosterol / Amphotericin B / Nystatin / AMB / Lanosterol 14 alpha-demethylase / Flucytosine / Colistin / Voriconazole / Polyene antimycotic / Fungemia / Candida glabrata

article published online: 1 june 2015 | doi: nchembio.1821 Nontoxic antimicrobials that evade drug resistance Stephen A Davis1,2, Benjamin M Vincent3,4, Matthew M Endo1,2, Luke Whitesell4, Karen Marchillo5,6, Dav

DocID: 1pvkH - View Document

Antifungals / F2G / Aspergillosis / Mycosis / Amphotericin B

PRESS RELEASE F2G Ltd announces the appointment of Ralf Schmid to the position of Chief Financial Officer MANCHESTER, UK – 11 JulyF2G Ltd, the UK-based antifungal drug discovery and development company, today a

DocID: 1oWNB - View Document

Aspergillus terreus / Terreus / Aspergillus / Amphotericin B / Multilocus sequence typing

Report 2014 Aspergillus working group

DocID: 1o3re - View Document

Amphotericin B Analogs Boast Lower Toxicity | June 8, 2015 Issue ­ Vol. 93 Issue 23 | Chemical & Engineering News  

DocID: 1gOcD - View Document